Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial

Ann S Knoop, Anne-Vibeke Lænkholm, Maj-Britt Jensen, Kirsten V Nielsen, Jørn Andersen, Dorte Nielsen, Bent Ejlertsen, Danish Breast Cancer Cooperative Group

20 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial'. Together they form a unique fingerprint.

Medicine & Life Sciences